cas 1142947-80-5|| where to buy 2-((3-(4-methylpiperazin-1-yl)phenyl)amino)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one

Название продукции:2-((3-(4-methylpiperazin-1-yl)phenyl)amino)-3,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one

IUPAC Name:2-{[3-(4-methylpiperazin-1-yl)phenyl]amino}-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-4-one

Упаковочная единица	Доступно для заказа	Цена ($)	Количество
CM152116-1g	1-2 Weeks	ǲƱƱ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1142947-80-5 regularly via the above email.

Дополнительные примечания

Verification code*

refresh

: Номер CAS:1142947-80-5; Молекулярная формула:C17H20N6O; Точка плавления:-; Smiles-код:O=C1C2=C(NC=C2)N=C(NC3=CC=CC(N4CCN(C)CC4)=C3)N1; Плотность:

: Номер в каталоге:CM152116; Молекулярная масса:324.39; Точка кипения:; Номер Mdl:; Хранение:Store at 2-8°C.

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Pyrrolopyrimidines; Fusion heterocyclic compounds have various biological activities, such as anticancer, antibacterial, antifungal and anti-inflammatory, and thus have been widely used in the field of medicinal chemistry. Pyrrolopyrimidines are a major class of fused heterocyclic compounds. Compared with single pyrrole and pyrimidine cores, pyrrolopyrimidines have more diverse and effective pharmacological characteristics as fusion scaffolds.